The changing epidemiology of resistance.

By Peter Hawkey, Annie M Jones. Journal of Antimicrobial Chemotherapy, 2009

835 citations recorded by the source corpus.

Subfields: Infectious Diseases, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/ad810163f14af077c0c1e382df4716a4e953c871

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Emily R. M. Sydnor
2. Curtis Huttenhower
3. Trish Perl
4. Nicola Segata

In Molecular Medicine

1. J. González-Alba
2. J. Galán
3. Trish Perl
4. Molly K. Gibson
5. Gautam Dantas
6. R. Cantón
7. Peter Hawkey

In Pharmacology

1. Emily R. M. Sydnor
2. Trish Perl
3. Molly K. Gibson
4. Gautam Dantas
5. R. Cantón

Citations in the corpus

• Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer (2016, background): “A well-known example is that of the blaCTX−M genes, which have become the most prevalent cause of extended-spectrum β-lactamases (ESBLs) in Enterobacteriaceae worldwide and a major cause of clinical treatment problems (Hawkey and Jones, 2009).”
• High-Specificity Targeted Functional Profiling in Microbial Communities with ShortBRED (2015, background): “For example, while Class A beta-lactamases are known to be the most diverse and widely disseminated class of beta-lactamase genes [20], the most abundant variants (CfxA and CblA) have been previously shown to be specific to Bacteroides species [21, 22].”
• Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands (2011, background): “The epidemiology of ESBL genes is changing rapidly and shows marked geographic differences in distribution of genotypes of blaCTX-M β-lactamases (5).”
• CTX-M Enzymes: Origin and Diffusion (2012, background): “Although different updates about CTX-M β-lactamases have been published (Bonnet, 2004; Livermore et al., 2007; Rossolini et al., 2008; Hawkey and Jones, 2009; Naseer and Sundsfjord, 2011), new data about dispersion and clonality of CTX-M producing isolates, molecular epidemiology, protein…”
• Hospital Epidemiology and Infection Control in Acute-Care Settings (2011, background): “Antibiotic resistance due to extended-spectrum beta-lactamase (ESBL)-producing organisms and carbapenemase-producing Enterobacteriaceae has now been reported globally (132).”